stock
CLOV · CLOVER HEALTH INVESTMENTS, CORP. /DE
What CLOVER HEALTH INVESTMENTS, CORP. /DE reports to the SEC, read from its filings.
Open in the appPrice
The live CLOV price and today's change.
Sign in to see thisChart
Thirty days of daily bars, with signal levels drawn on them.
Sign in to see thisSignals
The latest signal group Nakagai's scanner recorded on CLOV.
Sign in to see thisOptions positioning
Gamma exposure levels from the options market.
Sign in to see thisTechnicals
Trend, momentum and volatility gauges per timeframe.
Sign in to see thisWhat it is
- Industry
- Hospital & Medical Service Plans (SIC 6324)
- Filer (SEC EDGAR)
- EDGAR filing index
- Shares outstanding
- Not reported.
Key stats
Valuation
- P/E
- Locked
- P/S
- Locked
- P/B
- Locked
- Enterprise value
- Locked
- EV/EBIT
- Locked
- FCF yield
- Locked
Margins
- Gross
- —
- Operating
- -0.7%
- Net
- -0.7%
Returns
- ROE
- -4.9%
- ROA
- -2.5%
Health
- Current ratio
- 1.5x
- Debt/equity
- —
Deep value
- NCAV
- $141.38M
- NCAV per share
- —
- Price/NCAV
- Locked
- NNWC
- -$145.23M
- NNWC per share
- —
- Price/NNWC
- Locked
Valuation and the price multiples are built on the live price. Trailing twelve months to 2026-06-30; balance sheet at 2026-06-30.
Sign in to see thisDebt is long-term debt and its current portion. Commercial paper and short-term borrowings are not counted.
Results
| Period end | Revenue | Gross profit | Operating income | Net income | Filing |
|---|---|---|---|---|---|
| 2026-06-30 | $743.17M | — | $28.00M | $28.00M | 10-Q filed 2026-08-07 |
| 2026-03-31 | $749.19M | — | $27.33M | $27.33M | 10-Q filed 2026-08-07 Assembled from more than one filing; the filing above is only the newest of them. |
| 2025-12-31 | $487.71M | — | -$49.32M | -$49.32M | DEF 14A filed 2026-04-28 Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter. Assembled from more than one filing; the filing above is only the newest of them. |
| 2025-09-30 | $496.65M | — | -$24.38M | -$24.38M | 10-Q filed 2025-11-07 |
| 2025-06-30 | $477.62M | — | -$10.56M | -$10.58M | 10-Q filed 2026-08-07 |
| 2025-03-31 | $462.33M | — | -$1.27M | -$1.27M | 10-Q filed 2026-08-07 Assembled from more than one filing; the filing above is only the newest of them. |
| 2024-12-31 | $336.96M | — | -$21.45M | -$22.09M | DEF 14A filed 2026-04-28 Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter. Assembled from more than one filing; the filing above is only the newest of them. |
| 2024-09-30 | $330.99M | $81.21M | -$8.79M | -$9.15M | 10-Q filed 2025-11-07 Assembled from more than one filing; the filing above is only the newest of them. |
- Assets
- $720.33M
- Equity
- $376.26M
Balance as of 2026-06-30.
Ten years
| Fiscal year end | Revenue | Operating income | Net income | Free cash flow |
|---|---|---|---|---|
| 2025-12-31 | $1.92B | -$85.53M | -$85.55M | -$68.98M |
| 2024-12-31 | $1.37B | -$45.75M | -$43.01M | $33.29M |
| 2023-12-31 | $1.26B | -$205.33M | -$213.36M | -$145.25M |
| 2022-12-31 | $1.10B | -$286.66M | -$338.84M | -$208.39M |
| 2021-12-31 | $1.47B | -$636.99M | -$587.76M | -$283.05M |
| 2020-12-31 | $672.89M | -$92.71M | -$136.39M | -$119.19M |
| 2019-12-31 | $462.27M | -$183.20M | -$363.74M | -$159.90M |
Company filings
events
5% owners ()
The Vanguard Group
Stake update
Insiders, politicians and funds
Insider trades, last 90 days
Reynoso Jamie L.
CEO, Medicare Advantage
Sale$38,675Oct 5, 7:00 PM ET
Toy Andrew
Chief Executive Officer, Director
Sale$1,335,797Oct 2, 4:12 PM ET
Reynoso Jamie L.
CEO, Medicare Advantage
Sale$8,760Sep 18, 4:22 PM ET
OLDAKOWSKI JOSEPH FRANK
VP OF FINANCE AND CONTROLLER
Sale$14,709Sep 17, 5:29 PM ET
Wai Conrad
CEO, Counterpart Health
Sale$1,416,000Sep 16, 4:27 PM ET
Politician trades, last 90 days
No politician trades filed in the last 90 days.
News
Stories that named CLOV, and the market events around them.
Sign in to see thisBoard
The CLOV board could not be loaded.
Retry the CLOV boardnakagai
Signals on CLOV come from a rule, not a model.
Nakagai’s scanner records a signal the moment a strategy’s rule matches on the bars. Members read those signals on their own desk, where an agent journals the tape and briefs them in plain English.
Members post on the CLOV board